Farabi Pharmaceutical (XTEH:DFRB1) Pretax Margin %: % (As of . 20)


What is Farabi Pharmaceutical Pretax Margin %?

Farabi Pharmaceutical XTEH:DFRB1 Pretax Margin % is % as of . 20.

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Farabi Pharmaceutical's Pre-Tax Income for the three months ended in . 20 was IRR0.00 Mil. Farabi Pharmaceutical's Revenue for the three months ended in . 20 was IRR0.00 Mil. Therefore, Farabi Pharmaceutical's pretax margin for the quarter that ended in . 20 was %.

The historical rank and industry rank for Farabi Pharmaceutical's Pretax Margin % or its related term are showing as below:


XTEH:DFRB1's Pretax Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 7.285
* Ranked among companies with meaningful Pretax Margin % only.

Farabi Pharmaceutical  (XTEH:DFRB1) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.

Farabi Pharmaceutical Pretax Margin % Related Terms

Farabi Pharmaceutical Pretax Margin % Historical Data

* Premium members only.

The historical data trend for Farabi Pharmaceutical's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Farabi Pharmaceutical Pretax Margin % Chart

Farabi Pharmaceutical Annual Data
Trend
Pretax Margin %

Farabi Pharmaceutical Quarterly Data
Pretax Margin %

XTEH:DFRB1 vs IMNPQ, INNV: Pretax Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Farabi Pharmaceutical's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Farabi Pharmaceutical Pretax Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Farabi Pharmaceutical's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Farabi Pharmaceutical's Pretax Margin % falls into.


Farabi Pharmaceutical Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Farabi Pharmaceutical's Pretax Margin for the fiscal year that ended in . 20 is calculated as

Pretax Margin=Pre-Tax Income (A: . 20 )/Revenue (A: . 20 )
=/
= %

Farabi Pharmaceutical's Pretax Margin for the quarter that ended in . 20 is calculated as

Pretax Margin=Pre-Tax Income (Q: . 20 )/Revenue (Q: . 20 )
=/
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Pretax Margin % →
What does a Pretax Margin % of % mean?
Farabi Pharmaceutical (XTEH:DFRB1) has a Pretax Margin % of % as of . 20. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Farabi Pharmaceutical and its competitors.
Is Farabi Pharmaceutical's Pretax Margin % too high?
Farabi Pharmaceutical's current Pretax Margin % is %.
How does Farabi Pharmaceutical's Pretax Margin % compare to IMNPQ and INNV?
Farabi Pharmaceutical's Pretax Margin % of % can be compared against companies in the Drug Manufacturers industry. The industry median Pretax Margin % is 7.29. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Drug Manufacturers company?
The median Pretax Margin % among Drug Manufacturers companies is 7.29, based on 956 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Farabi Pharmaceutical and its competitors. For the Drug Manufacturers industry, the median Pretax Margin % is 7.29 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Farabi Pharmaceutical's current Pretax Margin % is %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Farabi Pharmaceutical stock overvalued right now?
Farabi Pharmaceutical (XTEH:DFRB1) has a current Pretax Margin % of %. The current Pretax Margin % is %. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Farabi Pharmaceutical (XTEH:DFRB1), the current Pretax Margin % is % as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Farabi Pharmaceutical Business Description

Address South Kheradmand, No. 45, First Floor, Tehran, IRN, 1584853114
Farabi Pharmaceutical is a pharmaceutical company based in Iran. It produces various oral antibiotic-related and non-antibiotic products and dietary supplements. The company develops anti-migraine, antivirals, cholesterol, diabetic, cardiovascular, gastrointestinal, neuroleptics, anti-prostatic and anti-inflammatory and pain release drugs. It offers products in the form of tablet, capsule and suspensions which include Amoxicillin, Cefixime, Azithromycin, Ciprofloxacin, Nitroglycerin, Repaglinide, Orlistat, Domperidone, among others.